Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scholar Rock Holding Corp
(NQ:
SRRK
)
14.79
+0.79 (+5.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Scholar Rock Holding Corp
< Previous
1
2
3
4
Next >
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
March 19, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 15, 2024
From
Scholar Rock, Inc.
Via
Business Wire
Scholar Rock Holding Corp. (NASDAQ: SRRK) Near the Top of Equities by Percentage Gain on 10/25
October 25, 2023
Via
Investor Brand Network
Scholar Rock Holding Corp. (NASDAQ: SRRK) Near the Top of Equities by Percentage Gain on 10/6
October 06, 2023
Via
Investor Brand Network
Scholar Rock to Participate in Upcoming Investor Conferences
February 28, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 16, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
February 15, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
February 06, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
January 25, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
January 23, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 12, 2024
From
Scholar Rock
Via
Business Wire
Scholar Rock Provides Corporate Update and Highlights Priorities for 2024
January 04, 2024
From
Scholar Rock, Inc.
Via
Business Wire
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 17, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress
November 07, 2023
From
Scholar Rock, Inc.
Via
Business Wire
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
November 03, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock to Participate in Upcoming Investor Conferences
November 02, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting
October 19, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
October 16, 2023
From
Scholar Rock Holding Corporation
Via
Business Wire
Scholar Rock Announces Pricing of Upsized Public Offering of Common Stock
October 11, 2023
From
Scholar Rock Holding Corporation
Via
Business Wire
Scholar Rock Announces Proposed Public Offering of Common Stock
October 11, 2023
From
Scholar Rock Holding Corporation
Via
Business Wire
Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders
October 11, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
September 19, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 15, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress
August 09, 2023
From
Scholar Rock
Via
Business Wire
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 13, 2023
From
Scholar Rock
Via
Business Wire
New 36-Month Apitegromab Extension Data Reinforce Long-Term Substantial and Sustained Improvement of Motor Function in Phase 2 TOPAZ Trial Patients with Nonambulatory Spinal Muscular Atrophy
June 30, 2023
From
Scholar Rock, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.